Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Suleman A, Aktar SJ, Ante Z, Liu N, et al. Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario. Br J Haematol 2023 Jul 20. doi: 10.1111/bjh.18972.
PMID: 37474340


Privacy Policy